The emergence of IP rich companies is the new corporate governance challenge. This is because IP is largely invisible, not only in the financial accounts, but also more generally in corporate law theory and the legal framework. The research in my new book In the modern era, all companies, large and small, have intellectual property (IP) rights, sometimes across multiple jurisdictions. They are corporate IP owners. demonstrates why companies need to communicate more about how they manage corporate intellectual property (IP) rights portfolios and their strategy for delivering shareholder value. Depending on their business model and corporate objectives, companies add value via their corporate IP assets in different ways to achieve their goals. At the same time, the shift to intangibles and IP assets as the major driver of value in business is clear and unstoppable. Since the Global Financial Crisis ten years ago there has been a renewed interest in our current understanding of capitalism. As a result, shareholders, business people, stakeholders and the public, seek more relevant, accurate information about IP-dependent business models and their impact on commercial value.
|Dr. Janice Denoncourt|
contributes to the legal and economic literature for readers interested in what lies behind the headlines. The foreword is written by Professor Nicolas Binctin, . As for the future of the Silicon Valley biotech company Theranos, Inc., the company has since made hundreds of staff redundant to avert becoming insolvent.